Tapewire

Nasdaq · USD

TIPT

TIPTREE INC.

Export transactions ↓
Tapewire entity
5239
SEC CIK
0001393726
Parsed reports
515

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 22, 2021 Filed Nov 22, 2021 17:04 UTC
Maultsby RandyDirector · President
Exercise / conversionCommon Stock 33,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001393726-21-000123 · wf-form4_163761867871821.xml · nonDerivative · entry 1

Maultsby Randy · CIK 0001855788 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The acquisition of the common stock resulted from the vesting of an equal number of performance restricted stock units ("PRSUs") granted on August 4, 2021. Each PRSU represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock.

Read SEC document
November 22, 2021 Filed Nov 22, 2021 22:03 UTC
Ilany JonathanDirector · Chief Executive Officer
Exercise / conversionPerformance Restricted Stock Units · Derivative 100,000 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000121 · wf-form4_163761856970650.xml · derivative · entry 5

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

F3 · derivative.exercise_date: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

F3 · derivative.expiration_date: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

Read SEC document
November 22, 2021 Filed Nov 22, 2021 22:03 UTC
Ilany JonathanDirector · Chief Executive Officer
GiftCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000121 · wf-form4_163761856970650.xml · nonDerivative · entry 2

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,863

F2 · kind: The reporting person gifted the vested portion of the PRSUs on November 22, 2021 to a family trust of which the reporting person has no control or beneficial interest.

Read SEC document
November 22, 2021 Filed Nov 22, 2021 22:03 UTC
Ilany JonathanDirector · Chief Executive Officer
Exercise / conversionCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001393726-21-000121 · wf-form4_163761856970650.xml · nonDerivative · entry 1

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The acquisition of the common stock resulted from the vesting of an equal number of performance restricted stock units ("PRSUs") granted on August 4, 2021. Each PRSU represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock.

Read SEC document
November 22, 2021 Filed Nov 22, 2021 17:01 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
Exercise / conversionPerformance Restricted Stock Units · Derivative 100,000 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000119 · wf-form4_163761843624713.xml · derivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

F2 · derivative.exercise_date: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

F2 · derivative.expiration_date: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

Read SEC document
November 22, 2021 Filed Nov 22, 2021 17:01 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
Exercise / conversionCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001393726-21-000119 · wf-form4_163761843624713.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,722,949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The acquisition of the common stock resulted from the vesting of an equal number of performance restricted stock units ("PRSUs") granted on August 4, 2021. Each PRSU represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock.

Read SEC document
October 06, 2021 Filed Oct 7, 2021 14:00 UTC GrantCommon Stock 3,184 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000107 · wf-form4_163361523390169.xml · nonDerivative · entry 1

Goldwasser Lesley · CIK 0001465575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,534

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
October 06, 2021 Filed Oct 7, 2021 10:02 UTC GrantCommon Stock 3,184 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000109 · wf-form4_163361534398389.xml · nonDerivative · entry 1

Smith Bradley E. · CIK 0001579089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,380

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
October 06, 2021 Filed Oct 7, 2021 09:58 UTC GrantCommon Stock 2,547 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000105 · wf-form4_163361512351779.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,365

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
October 06, 2021 Filed Oct 7, 2021 09:57 UTC GrantCommon Stock 2,547 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000103 · wf-form4_163361502878774.xml · nonDerivative · entry 1

Mielle Dominique · CIK 0001759191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,124

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
August 04, 2021 Filed Aug 5, 2021 14:23 UTC GrantPerformance Restricted Stock Units · Derivative 500,000 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000097 · wf-form4_162818777840567.xml · derivative · entry 2

Maultsby Randy · CIK 0001855788 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

Read SEC document
August 04, 2021 Filed Aug 5, 2021 18:20 UTC
Ilany JonathanDirector · Chief Executive Officer
GrantPerformance Restricted Stock Units · Derivative 1,500,000 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000095 · wf-form4_162818759465047.xml · derivative · entry 4

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: Common Stock · 1,500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

Read SEC document
August 04, 2021 Filed Aug 5, 2021 14:17 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
GrantPerformance Restricted Stock Units · Derivative 1,500,000 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000093 · wf-form4_162818741043273.xml · derivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: Common Stock · 1,500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

Read SEC document
July 06, 2021 Filed Jul 7, 2021 20:41 UTC GrantCommon Stock 3,218 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000077 · wf-form4_162569047579780.xml · nonDerivative · entry 1

Goldwasser Lesley · CIK 0001465575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,350

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
July 06, 2021 Filed Jul 7, 2021 16:39 UTC GrantCommon Stock 3,218 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000075 · wf-form4_162569034525427.xml · nonDerivative · entry 1

Smith Bradley E. · CIK 0001579089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,196

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
July 06, 2021 Filed Jul 7, 2021 16:37 UTC GrantCommon Stock 2,575 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000073 · wf-form4_162569022799414.xml · nonDerivative · entry 1

Mielle Dominique · CIK 0001759191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,577

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
July 06, 2021 Filed Jul 7, 2021 16:35 UTC GrantCommon Stock 2,575 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000071 · wf-form4_162569013139739.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,818

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
June 04, 2021 Filed Jun 4, 2021 20:06 UTC
Ilany JonathanDirector · Chief Executive Officer
PurchaseCommon Stock 430 $10.00 $4,300.00
Disclosure

SEC source: 0001393726-21-000062 · wf-form4_162283718374132.xml · nonDerivative · entry 2

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401K

Disclosed balance after: 34,400

Read SEC document
June 04, 2021 Filed Jun 4, 2021 20:06 UTC
Ilany JonathanDirector · Chief Executive Officer
PurchaseCommon Stock 1,500 $9.96 $14,941.50
Disclosure

SEC source: 0001393726-21-000062 · wf-form4_162283718374132.xml · nonDerivative · entry 1

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By IRA

Disclosed balance after: 144,019

Read SEC document
April 07, 2021 Filed Apr 9, 2021 15:02 UTC GrantCommon Stock 3,690 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000028 · wf-form4_161798052036464.xml · nonDerivative · entry 1

Goldwasser Lesley · CIK 0001465575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,132

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
April 07, 2021 Filed Apr 9, 2021 11:06 UTC GrantCommon Stock 3,690 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000034 · wf-form4_161798079896030.xml · nonDerivative · entry 1

Smith Bradley E. · CIK 0001579089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,978

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
April 07, 2021 Filed Apr 9, 2021 11:05 UTC GrantCommon Stock 2,952 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000032 · wf-form4_161798070944652.xml · nonDerivative · entry 1

Mielle Dominique · CIK 0001759191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,002

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
April 07, 2021 Filed Apr 9, 2021 11:03 UTC GrantCommon Stock 2,952 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000030 · wf-form4_161798062349971.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,243

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
March 17, 2021 Filed Mar 18, 2021 16:09 UTC PurchaseCommon Stock 36,685 $8.87 $325,506.01
Disclosure

SEC source: 0001393726-21-000026 · wf-form4_161609817101751.xml · nonDerivative · entry 2

Inayatullah Arif · CIK 0001499674 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,097,094

F2 · price: This purchase was executed in multiple purchases at prices ranging from $8.73 to $9.10, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 17, 2021 Filed Mar 18, 2021 16:09 UTC PurchaseCommon Stock 48,315 $7.68 $370,914.26
Disclosure

SEC source: 0001393726-21-000026 · wf-form4_161609817101751.xml · nonDerivative · entry 1

Inayatullah Arif · CIK 0001499674 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,060,409

F1 · price: This purchase was executed in multiple purchases at prices ranging from $7.64 to $7.71, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 16, 2021 Filed Mar 17, 2021 11:46 UTC PurchaseCommon Stock 900 $7.87 $7,083.00
Disclosure

SEC source: 0001393726-21-000024 · wf-form4_161599597176749.xml · nonDerivative · entry 2

Inayatullah Arif · CIK 0001499674 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,012,094

Read SEC document
March 16, 2021 Filed Mar 17, 2021 11:46 UTC PurchaseCommon Stock 39,100 $7.32 $286,133.80
Disclosure

SEC source: 0001393726-21-000024 · wf-form4_161599597176749.xml · nonDerivative · entry 1

Inayatullah Arif · CIK 0001499674 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,011,194

F1 · price: This purchase was executed in multiple purchases at prices ranging from $6.75 to $7.68, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 16, 2021 Filed Mar 17, 2021 15:45 UTC
Ilany JonathanDirector · Chief Executive Officer
PurchaseCommon Stock 4,000 $6.96 $27,836.00
Disclosure

SEC source: 0001393726-21-000023 · wf-form4_161599591112641.xml · nonDerivative · entry 2

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401K

Disclosed balance after: 33,970

F1 · price: This purchase was executed in multiple purchases at prices ranging from $6.76 to $6.96, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 16, 2021 Filed Mar 17, 2021 15:45 UTC
Ilany JonathanDirector · Chief Executive Officer
PurchaseCommon Stock 1,000 $7.83 $7,831.00
Disclosure

SEC source: 0001393726-21-000023 · wf-form4_161599591112641.xml · nonDerivative · entry 1

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By IRA

Disclosed balance after: 142,519

Read SEC document
March 16, 2021 Filed Mar 17, 2021 11:44 UTC PurchaseCommon Stock 20,000 $7.79 $155,720.00
Disclosure

SEC source: 0001393726-21-000022 · wf-form4_161599584637458.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,291

F1 · price: This purchase was executed in multiple purchases at prices ranging from $7.77 to $7.80, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 16:30 UTC GrantCommon Stock 5,857 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000006 · wf-form4_161012339903361.xml · nonDerivative · entry 1

Goldwasser Lesley · CIK 0001465575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,442

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 11:34 UTC GrantCommon Stock 4,881 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000010 · wf-form4_161012364812975.xml · nonDerivative · entry 1

Smith Bradley E. · CIK 0001579089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,288

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 11:33 UTC GrantCommon Stock 4,881 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000008 · wf-form4_161012356926736.xml · nonDerivative · entry 1

Mielle Dominique · CIK 0001759191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,050

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 11:28 UTC GrantCommon Stock 4,881 $0.00 $0.00
Disclosure

SEC source: 0001393726-21-000004 · wf-form4_161012331151607.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,291

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
November 12, 2020 Filed Nov 13, 2020 13:11 UTC PurchaseCommon Stock 20,000 $5.22 $104,400.00
Disclosure

SEC source: 0001393726-20-000277 · wf-form4_160529105599993.xml · nonDerivative · entry 1

Mielle Dominique · CIK 0001759191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,169

Read SEC document
October 29, 2020 Filed Oct 30, 2020 09:51 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,300 $5.02 $6,529.90
Disclosure

SEC source: 0001393726-20-000269 · wf-form4_160406585445420.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,622,949

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.98 to $5.05, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 28, 2020 Filed Oct 29, 2020 10:12 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,466 $5.13 $12,650.58
Disclosure

SEC source: 0001393726-20-000267 · wf-form4_160398073241536.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,621,649

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.06 to $5.16, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 27, 2020 Filed Oct 29, 2020 10:12 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,466 $5.22 $12,870.05
Disclosure

SEC source: 0001393726-20-000267 · wf-form4_160398073241536.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619,183

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.20 to $5.24, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 26, 2020 Filed Oct 27, 2020 10:04 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,466 $5.22 $12,879.92
Disclosure

SEC source: 0001393726-20-000265 · wf-form4_160380745212546.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,616,717

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.20 to $5.24, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 23, 2020 Filed Oct 27, 2020 10:04 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,477 $5.27 $13,056.27
Disclosure

SEC source: 0001393726-20-000265 · wf-form4_160380745212546.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,614,251

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.20 to $5.30, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 22, 2020 Filed Oct 23, 2020 10:02 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,477 $5.29 $13,113.24
Disclosure

SEC source: 0001393726-20-000263 · wf-form4_160346175955012.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,611,774

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.28 to $5.32, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 21, 2020 Filed Oct 23, 2020 10:02 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,477 $5.34 $13,232.13
Disclosure

SEC source: 0001393726-20-000263 · wf-form4_160346175955012.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,609,297

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.30 to $5.37, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 20, 2020 Filed Oct 21, 2020 10:14 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,477 $5.30 $13,118.19
Disclosure

SEC source: 0001393726-20-000259 · wf-form4_160328966239623.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,606,820

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.25 to $5.32, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 19, 2020 Filed Oct 21, 2020 10:14 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,477 $5.26 $13,036.45
Disclosure

SEC source: 0001393726-20-000259 · wf-form4_160328966239623.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,604,343

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.24 to $5.30, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 16, 2020 Filed Oct 19, 2020 11:24 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,052 $5.25 $16,010.79
Disclosure

SEC source: 0001393726-20-000256 · wf-form4_160312107175246.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,601,866

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.15 to $5.30 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 11:24 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,052 $5.16 $15,736.11
Disclosure

SEC source: 0001393726-20-000256 · wf-form4_160312107175246.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,598,814

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.11 to $5.20, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 14, 2020 Filed Oct 15, 2020 10:27 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,052 $5.17 $15,781.89
Disclosure

SEC source: 0001393726-20-000254 · wf-form4_160277201937025.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,595,762

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.14 to $5.20 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 13, 2020 Filed Oct 15, 2020 10:27 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,052 $5.19 $15,849.04
Disclosure

SEC source: 0001393726-20-000254 · wf-form4_160277201937025.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,592,710

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.17 to $5.21, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 12, 2020 Filed Oct 13, 2020 10:41 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,052 $5.22 $15,919.23
Disclosure

SEC source: 0001393726-20-000244 · wf-form4_160260009356217.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,589,658

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F4 · price: This purchase was executed in multiple purchases at prices ranging from $5.16 to $5.25, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 09, 2020 Filed Oct 13, 2020 10:41 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,852 $5.22 $14,876.03
Disclosure

SEC source: 0001393726-20-000244 · wf-form4_160260009356217.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,586,606

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.15 to $5.28 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.